Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Open in API
Filings indexed 2,231 across all filing types
Latest filing 2025-12-09 Fund Information / Fact…
Country TW Taiwan
Listing TW 1789

About SPT

https://www.scinopharm.com/tw

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
114年11月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 神隆, with data for November of the 114th year of the Republic of China calendar (equivalent to 2025). It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting practices. The document is very short (774 characters) and contains no detailed financial statements, management discussion, or comprehensive analysis. It appears to be a brief financial summary or factsheet rather than a full report or announcement of a meeting or vote. There is no indication of it being an earnings release, annual or interim report, or any regulatory filing. Given the concise nature and focus on key financial figures, the best fitting category is Fund Information / Factsheet (FS).
2025-12-09 Chinese
本公司受邀參加永豐金證券舉辦之線上法人說明會
Investor Presentation Classification · 90% confidence The document is a brief announcement about the company (1789 神隆) participating in an online investor presentation hosted by 永豐金證券. It mentions the date and time of the event and that the company will discuss its publicly released Q3 financial figures and operational overview. The document does not contain actual financial statements or detailed analysis but rather informs about the event where such information will be presented. The length is short (657 characters), and it serves as a notice of the investor presentation rather than the presentation itself or a financial report. Therefore, the appropriate classification is Investor Presentation (IP).
2025-12-08 Chinese
114年11月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tabular data showing shareholdings of insiders, including directors, chairman, general manager, and their related parties. It lists share types, quantities held at different times, increases and decreases in holdings, and other related information. The content is focused on insider share ownership and transactions, not on financial results, management changes, or meeting materials. There is no indication of it being a report or announcement of a report, nor is it a transcript or legal proceeding. This type of document matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is substantial and contains actual data, not just an announcement or certification. Therefore, the correct classification is DIRS with high confidence.
2025-12-08 Chinese
114年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current holdings, pledged shares, and related information. It is a disclosure of insider shareholdings and pledges, typical of a Director's Dealing or insider shareholding notification. There is no indication of financial results, management discussion, or report publication. The document is not a report but a regulatory disclosure of insider shareholdings. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2025-12-08 Chinese
114年第3季海外子公司投資
Regulatory Filings Classification · 90% confidence The document is a financial disclosure related to investment in overseas subsidiaries, showing investment amounts, shareholding percentages, and recognized investment gains or losses for the current period. It is relatively short (772 characters) and appears to be a regulatory disclosure of investment details rather than a full financial report. There is no indication that this is a full annual or interim report, audit report, or earnings release. It does not contain management discussion or detailed financial statements. The document resembles a regulatory filing or announcement of investment-related financial data, typical of a Regulatory Filings (RNS) category, which is a fallback for miscellaneous regulatory disclosures that do not fit other categories.
2025-11-13 Chinese
114年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning the company's investments in mainland China. It includes specific financial figures, investment methods, and regulatory approval limits. The content is focused on investment details rather than a full financial report or announcement. The document length is short (1486 characters), but it contains substantive financial data related to investments. This type of disclosure typically falls under Regulatory Filings (RNS) as it is a regulatory-required investment disclosure rather than a full report like an Annual Report or Interim Report. It is not an announcement of a report, nor a certification or a voting result. Therefore, the best classification is Regulatory Filings (RNS).
2025-11-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.